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• Examination of the changes in experimental autog- 
enous vein grafts has presented some important results for 
both human surgical grafts and also for atherosclerosis. We 
have developed a microsurgical grafting model in the rat, by 
anastomosing 4mm of the iliolumbar vein into the iliac 
artery. The primary cellular response involves the prolifera- 
tion and migration ofendothelium and smooth muscle cells 
from the adjacent artery. The majority of this activity is 
complete within the first 4 weeks after grafting. This develop- 
ment of the new cells in the vein graft is described as intimal 
(or neo-intimal) hyperplasia. The revascularisation by the 
vasa vasorum and the re-establishment of sympathetic 
reinnervation of the graft have both been quantitated in 
detail. In addition, we are now examingfactors that influence 
the intimal hyperplastic response, specifically nicotine, cho- 
lesterol and high blood pressure. These factors, as well as 
being of clinical importance, also give an indication of the 
pathogenesis of intimal hyperplasia. In this article we briefly 
review the work that we have completed over the last 15years 
and its relevance to the experimental and clinical research 
literature on intimal hyperplasia. 
INTRODUCTION 
• The number of patients presenting with disorders of 
the vascular system (especially occlusive conditions) is 
increasing(l). The advent of modern surgical techniques, 
particularly the use of microsurgery and the availability of 
numerous vascular prostheses, have enhanced the vascu- 
lar surgeon's ability to "bridge" arterial defects, both 
occlusive and traumatic. 
The autogenous vein segment is still by far the most 
commonly used graft material. By as long ago as 1975 it 
was estimated that in the USA alone 100 000 aorto- 
coronary bypasses were being performed annually(l). 
Various other materials have also been used as by-pass 
conduits. Synthetic prostheses were initially used by 
Voorhees in 1952(2) and subsequently numerous syn- 
thetic materials have been tried (2,3,4). 
In modern western society atherosclerosis of the 
coronary arteries is present more commonly than ever 
before(5). Atherosclerosis is characterised by a focal 
thickening of the vessel wall, specifically the intima(6). 
This thickening consists of accumulations of fat, layers of 
collagen-like fibres, and a number of cell populations 
(7,8). The use of vein grafts to bypass atherosclerotic 
changes in coronary arteries has been developed over the 
lastSOyears(l). 
THE VEIH GRAFT MODEL; A HISTORICAL 
PERSPECTIVE 
• Our initial research objective was to develop an 
experimental model for testing the antigenicity of venous 
tissue, when placed into arteries as vein-to-artery grafts. At 
that time (mid 1970s) the coronary artery by-pass opera- 
tion for relief of myocardial ischaemia had just become 
very successful and popular. This procedure involved 
inserting segments of saphenous vein from the leg into 
coronary arteries to by-pass seriously narrowed (stenosed) 
vessels. These were "autografts", in that vein segments 
were taken from the same individual who required the 
graft, thus avoiding immune response complications. How- 
ever, some individuals who had grafts in place for a few 
years had subsequently developed stenosis of the grafts 
and it was necessary to explore the possibility of using 
donor vein grafts from other individuals (allografts). Our 
first task was to develop an experimental model in which 
to determine the antigenicity of vein grafts. 
  
  
We subsequently developed a precise experimental 
model by placing a small, 4mm, segment of the iliolumbar 
vein into the iliac artery in rats. Both vessels were 1mm in 
diameter and although the microsurgery was technically 
difficult, the size match was excellent. Eight micro-sutures 
of 10.0 Ethilon were inserted at each anastomosis and we 
developed a "four handed" reliable technique for ensur- 
ing even tension and spacing between sutures. The patiency 
rate for these grafts was 80-90% which was excellent for 
such difficult procedures (9,10). 
HISTOGEHESIS OF VEIH GRAFT TISSUES 
• We conducted detailed histological examinations 
of our experimental grafts from one to 18 weeks after 
insertion and found that nearly all of the original graft 
tissue was phagocytosed by 2 weeks after surgery; this was 
replaced by regenerated tissues, presumably from the 
host. The vein graft wall at operation was only 50-80 urn 
thick and consisted mostly of collagen, with very few cells. 
Thus, macrophages removed most of this tissue rapidly 
after surgery and a new vessel regenerated (11). This 
regenerative response, whereby a new "pseudo-artery" 
with endothelium, smooth muscle and elastin had devel- 
oped, occured within 4 weeks (12,13). 
One striking feature of these vein grafts was the 
development of the intima, a layer which was structurally 
analogous to the media in an artery. In an artery the intima 
consists of a layer of endothelial cells, a subendothelial 
layer of amorphous material and an inner elastic lamina. 
The media has concentrations of smooth muscle cells 
(SMC) interspersed with elastin; the adventita has con- 
nective tissue and contains the nerves and nutrient blood 
vessels (vasa vasorum). 
Contrastingly, vein grafts contain endothelium plus 
smooth muscle and elastin (equivalent to an arterial 
media) that develops on the inner (lumenal) aspect of the 
"old" inner elastic lamina of the original vein graft seg- 
ment. This "old" lamina is 1 urn thick and survives in the 
vein graft for many months after insertion. It provided a 
most useful marker for the vein graft intima (14). Other 
studies have shown that during the initial month after graft 
placement, histological changes are associated with in- 
flammation and regeneration of the endothelium (15). 
Once the endothelial lining had been established, 
over a carpet of platelets lying directly upon the raw graft 
surface of the original elastic lamina (12), by 15 days after 
surgery, SMC started to migrate into the elastic lamina and 
the overlying endothelium (16,17). 
The origin of SMC found within the graft intima 
after this initial regenerative period is not clear (14). Using 
radioactive thymidine labelling techniques, it has been 
shown that proliferation of SMC reduced to background 
levels three months after graft placement (15). Histologi- 
cally, intimal SMC appear similar to those of the media, 
with many in a "transitionary" phenotypic state (18). This 
would explain Fuchs et al, (1978) findings of booth 
fibroblasts and SMC within the media (19). These modi- 
fied SMC were oriented longitudinally rather than in the 
predominantly circular arrangement which is typical for 
vein media (18). Between the cells of the intima were 
collagen fibres (arranged longitudinally), and rarely some 
elastin (20). Other researches have demonstrated "trans- 
formation" of myocytes to fibroblast-like cells occuring in 
association with the deterioration of other SMC within the 
vascular wall of grafts. A reduction inmyofilaments and an 
increase in rough endoplasmic reticulum in SMC sig- 
nalled the change in function from contractile to secretory 
(21). 
The connective tissue content of the hyperplastic 
intima exhibits a specific pattern: remaining SMC become 
separated by collagen, elastin, and fibro-matrix into a 
layered functional architecture. The myofibroblasts were 
mainly associated with regions of active intimal hyperplasia 
(22). The morphology of intimal hyperplasia is similar in 
various vascular graft types (human vein, bovine vein, 
Dacron) (23). 
In human subjects with aorto-coronary bypasses 
intimal hyperplasia occurs at varying rates (24,25). Intimal 
hyperplasia may reduce lumenal diameter continuously 
until stenosis occurs, or reduce the diameter to a certain 
level and remain unchanged (24). The clinical conse- 
quences are obviously very serious. Very recent work from 
our group, using pulse labelling of tritiated thymidine, has 
shown conclusively that the SMC are derived from the 
media of the adjacent artery (Figure 1) (26). 
REGENERATING CELL POPULATIONS 
• Another major direction of this research on the 
histogenesis of intimal hyperplasia has been to quantitate 
the intracellular changes that occur in regenerating vascu- 
lar graft tissues. 
Smooth muscle cells. 
A combination of electron microscopy and mor- 
phometry was used to show that SMC in the first few weeks 
after grafting change their intracellular components to a 
"synthetic" functional type, where they synthesize cyto- 
plasmic and extracellular matrix components. The con- 
tractile filaments are relatively sparse in these cells as they 
build up other cytoplasmic elements. Later, when these 
cells have proliferated, migrated and matured they be- 
come filled with contractile filaments. A great deal of 
research in vitro has been devoted to characterising these 
so-called "phenotypes" of smooth muscle: synthetic or 
contractile (17). This research has been directed towards 
understanding SMC changes in vascular pathology, par- 
ticularly atherosclerosis. Our research in the vein grafts 
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FIGURE LA diagramatic representation of cellular changes in vein grafts over 28 days after insertion. Labelling indices for tritiatedthymidine incoportation 
and autoradiographic labelling are shown at the edges of the diagrams. 
  
has shown how adaptable SMC are in vivo and how quickly 
they can modulate their phenotype. 
Endothelial cells. 
Scanning electron microscopy (SEM) was used in 
another series of experimental vein grafts to investigate the 
growth and maturation of endothelial cells. Actually they 
were derived from the adjacent artery, by mitotic division, 
which was maximal at 3 days after grafting. A sheet of 
endothelium then migrated across the anastomosis and 
covered the 4mm of the graft by 15 days after grafting. 
Maturation of the endothelial cells, as evidenced by growth 
and development of overlapping tight inter-cellular junc- 
tions, was analysed in detail. This is a most important 








barriers to macro-molecules which are not normally al- 
lowed to escape the blood stream. Junctions were mature 
by 8 weeks after surgery. This was observed directly by 
SEM and confirmed experimentally by perfusing the 
grafted rats with Evan 's Blue Dye (EBD) one hour prior 
to sacrifice, at the various times after graft insertion. EBD 
binds to plasma albumin which does not normally pen- 
etrate/permeate the intact endothelium. Our data showed 
a direct correlation between the distribution of EBD 
staining in the grafts with the maturation of endothelial cell 
junctions (12). 
Recent transmission electron microscopic studies 
by our group examining endothelial cells regenerating in 
vein grafts have produced some interesting findings. En- 
dothelial cells in vein grafts have significantly greater 
proportions of vesicles, mitochondria and rough endoplas- 
mic reticulum when lining grafts (28). Although this 
should be expected during the early phase of endothelial 
cell division and migration, it is more difficult to explain 
why the concentrations of these cytoplasmic elements 
continued to stay elevated well beyond this initial phase. In 
fact, they remained high up to at least 52 weeks. We 
propose that the endothelial cells are permanently changed 
and as such may produce factors which influence the 
underlying intimal cellular populations. It is well accepted 
that endothelial cells produce an extensive array of growth 
factors, (29,30) many of which have the potential to 
influence SMC phenorype (31,32). A growth factor which 
appears to have close links with intimal hyperplasia and 
atherosclerosis is Platelet Derived Growth Factor (PDGF) 
(33). This may play an important role in the initiation of 
intimal hyperplasia. 
REVASCULARIZATION OF VEIN GRAFTS 
• This avenue of research was based upon observa- 
tions from traumatised arteries, where the adventitial 
covering had been removed, and intimal hyperplasia 
occured subsequently (35). Was it disruption to the vasa 
vasorum which initiated intimal hyperplasia, and did this 
operate in our model? We conducted a detailed quantita- 
tive analysis of the regeneration of vasa vasonim in a series 
of vein grafts. The data showed that vasa vasonim invaded 
the adventita of the graft very rapidly after the first week. 
These data were correlated with the development of 
intimal hyperplasia in these grafts and it was shown that 
growth of the intima was not associated with any compen- 
satory increase in vasa vasorum(35,36). 
The finding that vasa vasorum did not increase with 
increasing vein graft intimal hyperplasia suggested that as 
the intima became progressively thicker it might have 
become more ischaemic35. The rapidity of revasculariza- 
tion we reported in vein grafts has been used in studies on 
reversed autogenous clinical vein grafts (37,38). 
RESERVATION OF VEIN GRAFTS 
• As with the revascularization study there was evi- 
dence that sympathetic nerves (catecholaminergic nerves) 
could stimulate the growth of SMC (the major component 
of intimal hyperplasia in vein grafts). We hypothesised 
that regenerating nerves might grow across the vein graft 
and "attract" SMC from the adjacent artery and/or stimu- 
late their proliferation to build up a population of intimal 
muscle. To start with we had no evidence that sympathetic 
nerves regenerate in this situation so the first step was to 
study the vein grafts for evidence of nerves. It was obvious 
that sympathetic nerves grew very rapidly across the 
regenerating vein graft. They were derived from the sym- 
pathetic plexus surrounding the neighbouring iliac artery 
and vein. However, this regenerating nerve plexus was 
quite different from controls: the grafts' nerve fibres were 
finer, lacked varicosities and were further from the mus- 
cular tissue of the graft than in control arteries (39,40). 
Although we had established that sympathetic nerve re- 
generation occurs quite rapidly in our vein grafts, it is not 
possible to determine whether these regenerated sympa- 
thetic nerves stimulated SMC growth and proliferation in 
the intima. 
MANIPULATIONS OF IHTIMAL HYPERPLASIA 
IN VEIN GRAFTS 
• By the mid 1980s we had studied about 500 small 
vein grafts and had published a very substantial body of 
data: on re-endothelialization, revascularization, 
reinnervation and histogenesis of intimal hyperplasia. 
Therefore, it was considered that our grafts were an 
excellent model for investigating the influence of various 
factors on intimal hyperplasia. Could it be increased or 
decreased with various agents, drugs or nutritional re- 
gimes? 
The Influence of Nicotine on Vein Grafts 
There is abundant clinical evidence to show that 
people who smoke have an increased risk of developing 
vascular disease. If such individuals have vascular surgery 
(such as a vein graft) the probability of the graft failing, due 
to obliterative intimal hyperplasia is very high. We became 
very interested in this phenomenon because agents in 
smoke acting on tissue regeneration in our vein grafts 
might reveal mechanisms that could operate at the cellular 
level to induce intimal hyperplasia. Most of the literature 
to that time concentrated upon both carbon monoxide and 
nicotine and it became obvious that very little was known 
about what effect of these agents had on normal blood 
vessels. This information was essential before any manipu- 
lation on vein grafts could be attemped. 
Firstly there was evidence (from in vitro) that nico- 
years include: J McGeachie, F Prendergast, E Storrie, P 
Campbell, R Dilley, R Samuels, M Tennant, M Zimmerman 
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FIGURE 1. A diagramatic representation of the automated computer reconstruction ofintimal thick ness data for a 4 month old graft 
into a topographical map. 
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tine was mitogenic; thus we hypothesised that the 
increase in mitotic activity (if it did occur in vivo) might 
render the endothelial surface more permeable to macro- 
molecules in the circulating blood. This in turn might act 
upon the medial smooth muscle and initiate and promote 
arterial disease (seen in smokers). Our results showed 
convincingly that nicotine is mitogenic in arterial endothe- 
lium and there was a significantly high level of cell 
turnover under its influence (41,42). As a consequence, 
denuded areas of endotheliumoccured and this supported 
our hypothesis that the permeability of this layer would 
increase. When investigated further by electron micros- 
copy we found that the intercellular junctions between 
endothelial cells of nicotine affected rats were substan- 
tially less complex, and therefore more permeable, than 
normal (43,44,45). Furthermore, we confirmed this in- 
creased permeability with Horse-Radish Peroxidase, an 
extra cellular marker. 
Our experiments showed convincingly that nicotine 
increases endothelial cell turnover, creates denuded areas 
of endothelium and because it opens up the inter-cellular 
junctions, increases permeability. All these structural and 
functional features are firm evidence for increased suscep- 
tibility to arterial disease. 
Based upon this previous work, and upon research 
on intimal hyperplasia, we hypothesised that nicotine 
would probably accelerate re-endothelialization of the 
vein graft (due to its mitogenic effect). Then, because of 
retarded maturation of endothelial cell junctions, the 
prolonged increase in permeability would promote much 
- more intimal hyperplasia than we had seen previously (in 
"normal" grafts). There is no doubt that nicotine retards 
endothelial cell maturation, as evidenced by quantitative 
studies using Evan's Blue Dye staining of regenerating 
endothelial cells in the vein grafts(46). Moreover, SEM 
analyses of these same vessels show definite demage to 
endothelial cell junctions, similar to those we reported in 
arterial endothelium. 
Blood cholesterol levels 
As has been shown extensively in human studies, 
blood levels of cholesterol are intimately linked with 
arterial disease. However, the mechanisms involved have 
not been fully elucidated. It is known that raised choles- 
terol levels are a potent risk factor for intimal hyperplastic 
induced restenosis of vein grafts (47). Therefore, we have 
just completed a series of studies to investigate the effects 
of raised blood cholesterol on our model. Although the 
results are still very preliminary it appears that some 
potentiating effect is occuring even during the early stages 
following graft placement. 
MEASUREMENT OF INTIMAL HYPERPLASIA 
•       During all our studies to date, and many other 
published studies, the quantification of intimal hyperplasia 
has been difficult to perform with precision (48,49,50,51). 
For example, we had noticed for many years that focal 
areas of intimal hyperplasia occur not only in our grafts but 
in many other vessels (16). Did these focal areas represent 
regions which could become excessively thickened, or 
were more prone to degenerative arterial diseases., such as 
arteriosclerosis or atherosclerosis? Over the last 12-18 
months we have developed a whole range of computer- 
based techniques for the precise quantification of intimal 
hyperplasia. We can expeditiously make in excess of 5000 
thickness measurements on a single graft (52). These are 
also in a form that allows 3-dimensional reconstruction of 
a "map" of the intima (Figure 2). Thus we can now quan- 
titate small focal hyperplastic changes using a modern 
semi-automated approach and detect very early changes in 
the graft intima. 
CONCLUSION 
• Intimal hyperplasia in autogenous vein grafts may 
initially be a compensatory mechanism for alterations in 
haemodynamic stresses. The problem is that in some cases 
this hyperplasia becomes excessive resulting in graft fail- 
ure by stenosis, with obvious grave clinical consequences. 
The basis of the numerous studies we have been involved 
in over the last 15 years has been to examine the mecha- 
nism that contribute to graft restenosis. The primary cell 
population involved in intimal hyperplasia was thought to 
be SMC, as it makes up the greatest proportion of the 
intimal cell populations. However, it is becoming more 
evident that the regulatory roles of endothelial cells and 
blood-borne cells, specifically monocytes (that become 
tussue macrophages) are critical (34,53). The numerous 
growth regulatory substances that these cells produce and 
their location at the interface between the blood and the 
vessel wall makes them primary factors in the pathogen- 
esis of intimal hyperplasia. We will be continuing our 
research efforts in the future towards a better understand- 
ing of growth factors, endothelial cells and blood/blood- 
vessel wall interactions, with the objective of determining 
their roles in the regulation of SMC division and migra- 
tion, and consequent influence on both intimal hyperplasia 
in grafts, and atherosclerosis in general. 
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